TREATMENT ADVOCACY CENTER

Lobbying client · Virginia · filed 2025 to 2026

Advocacy, education, and research related to eliminating barriers to the treatment of SMI.

$50,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (67407), not by name.

Firms hired 1

TULIPIFERA STRATEGIES $50,000 6 filings

Reported by year 2 years

2026 $20,000 2 filings
2025 $30,000 4 filings

Issues lobbied 1

Health Issues 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 6 total

2T

TULIPIFERA STRATEGIES

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Aug 28, 2026

View → Q1

TULIPIFERA STRATEGIES

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted May 1, 2026

View → Q4

TULIPIFERA STRATEGIES

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $10,000 income · posted Jan 14, 2026

View → Q3

TULIPIFERA STRATEGIES

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $10,000 income · posted Nov 6, 2025

View → 2A

TULIPIFERA STRATEGIES

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $10,000 income · posted Aug 5, 2025

View → RR

TULIPIFERA STRATEGIES

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 1, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.